Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Using 'neurodivergent' as a catch‑all term is problematic—here's why (opens in a new tab)

medicalxpress.com · 2026-09-17

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 2 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Two of six check out. Three claims the study doesn't address.

  • 2 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Source paper

Source layer

The 4 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedThe term “neurodivergent” is being used more and more often in everyday conversation, on social media and even in scientific research.View evidenceHide evidence

Why this verdict

The paper profile supports that the terms are increasingly used in mental health and clinical/scientific literature, but the supplied abstract-level profile does not substantiate the broader claim about everyday conversation or social media. The story extends the paper-supported trend beyond the evidenced domain.

1

Study evidence

Included 134 studies (N = 151,134) identified in systematic searches up to Aug 1, 2025.

“Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review.”
Claim 2 of 6Not coveredThe review examined 134 scientific studies with more than 151,000 participants, mostly from the U.K. and U.S., and these studies covered education, work, mental health, identity, social connection, diagnosis and traits, support, and family/caregiver views.View evidenceHide evidence

As stated134 studies; more than 151,000 participants

Why this verdict

The abstract-level profile supports the review size: 134 studies and 151,134 participants. However, the claim also says the studies were mostly from the U.K. and U.S. and lists multiple topical domains; those details are not available in the supplied abstract-level profile, so the full claim cannot be verified at this depth.

1

Study evidence

Included 134 studies (N = 151,134) identified in systematic searches up to Aug 1, 2025.

“Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review.”
Claim 3 of 6Not coveredThe review found almost 20 different diagnoses linked to neurodivergence and neurodiversity, with autism and ADHD appearing most often, followed by dyslexia and dyspraxia; anxiety, depression, PTSD, stroke and traumatic brain injury also appeared.View evidenceHide evidence

As statedalmost 20 different diagnoses

Why this verdict

The abstract-level profile supports that the review found a heterogeneous range of diagnoses and that autism and ADHD appeared most often, followed by diagnoses including dyslexia, dyspraxia, anxiety disorder, and dyscalculia. It does not verify 'almost 20' diagnoses or the appearance of depression, PTSD, stroke, and traumatic brain injury. Those extra details may be in the full paper, but they are not verifiable from the supplied abstract-level profile.

1

Study evidence

Included 134 studies (N = 151,134) identified in systematic searches up to Aug 1, 2025.

“Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review.”
Claim 4 of 6Not coveredThe article says some studies mixed up “neurodivergent” and “neurodiverse,” even though the terms mean different things, and that there is no test that can separate neurodivergent from neurotypical.View evidenceHide evidence

Why this verdict

The abstract-level profile supports general conceptual concern about lack of specificity and recommends reserving 'neurodivergent' for identity/self-identification contexts, but it does not specifically verify that studies mixed up 'neurodivergent' and 'neurodiverse,' that the terms mean different things in the asserted way, or that there is no test separating neurodivergent from neurotypical. These specifics are not verifiable at the supplied evidence depth.

1

Study evidence

The terms 'neurodivergence' and 'neurodiversity' lack clinical/diagnostic specificity; the scoping review identified a heterogeneous range of associated diagnoses (most commonly autism and ADHD), and 21.6% of included studies did not specify any clinical diagnoses, which the authors state may introduce substantial heterogeneity in research focused on clinical categories.

“While neurodivergence and neurodiversity are valuable for capturing lived experience, their lack of specificity may introduce substantial heterogeneity in research focused on clinical categories.”
Claim 5 of 6SupportedThe authors say their new review found that academics cannot agree on what neurodivergent means or which clinical diagnoses it covers.View evidenceHide evidence

Why this verdict

The paper profile supports the gist that the review found heterogeneous and diagnostically nonspecific uses of neurodivergence/neurodiversity, and that the authors interpret this as a lack of clinical/diagnostic specificity. The wording 'academics cannot agree' is rhetorical, but it is consistent with the abstract-level finding of heterogeneous diagnosis mapping and the authors' interpretive conclusion.

1

Study evidence

Included 134 studies (N = 151,134) identified in systematic searches up to Aug 1, 2025.

“Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review.”
2

Study evidence

The terms 'neurodivergence' and 'neurodiversity' lack clinical/diagnostic specificity; the scoping review identified a heterogeneous range of associated diagnoses (most commonly autism and ADHD), and 21.6% of included studies did not specify any clinical diagnoses, which the authors state may introduce substantial heterogeneity in research focused on clinical categories.

“While neurodivergence and neurodiversity are valuable for capturing lived experience, their lack of specificity may introduce substantial heterogeneity in research focused on clinical categories.”
Claim 6 of 6SupportedOne in five studies used the words without naming any diagnosis, and about a third simply asked people to self-identify as neurodivergent rather than using a formal clinical assessment.View evidenceHide evidence

As statedone in five; a third

Why this verdict

The paper profile supports that 29 of 134 studies, or 21.6%, did not specify clinical diagnoses, matching 'one in five.' It also supports that 50 studies, or 37.3%, used self-identification, reasonably described as about a third. The claim is consistent with the abstract-level study-count findings, though the paper caveat is that these are study-level counts rather than participant-level prevalence.

1

Study evidence

In the set of included studies, participants labeled as neurodivergent/neurodiverse were most commonly identified via self-reported diagnoses (56 studies; 41.8%) or self-identification (50 studies; 37.3%), while 29 studies (21.6%) did not specify any clinical diagnoses.

“Participants were primarily identified through self-reported diagnoses (n = 56 [41.8%]) or self-identification (n = 50 [37.3%]).”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Important limitation: mapped diagnosis counts are study-level counts, not pooled participant-level prevalence estimates.

    The story reports study counts and participant totals, but its caveats do not mention that diagnosis frequencies are counts of studies rather than participant-level prevalence. This is an interpretation-relevant limitation because readers could mistake diagnosis frequencies for prevalence among the 151,134 participants.

    From Scoping review (JBI methods; PRISMA-ScR); Scoping review; descriptive mapping of identification/recruitment modes

10 things the story did carry across
  • The paper is a JBI/PRISMA-ScR scoping review of empirical mental health literature, not a new primary clinical study.
  • The review included 134 studies and 151,134 participants.
  • The paper quantitatively maps diagnoses associated with the terms 'neurodivergence' and 'neurodiversity' across included studies.
  • Most commonly reported associated diagnoses were autism and ADHD, with other common diagnoses including dyslexia, dyspraxia, anxiety disorder, and dyscalculia.
  • A notable fraction of studies, 29 studies or 21.6%, did not specify clinical diagnoses.
  • Participants were often identified through self-reported diagnoses or self-identification; self-identification occurred in 50 studies, or 37.3%.
  • The authors conclude that lack of diagnostic specificity may introduce substantial heterogeneity in research focused on clinical categories.
  • The authors recommend prioritizing precise diagnostic descriptors in clinical practice and research involving clinically defined conditions, while reserving 'neurodivergent' for identity/self-identification contexts.
  • Important limitation: heterogeneity in study designs, reporting practices, and operational definitions limits comparability across included studies.
  • Important limitation: substantial reliance on self-report and self-identification introduces variability in diagnostic ascertainment and potential misclassification.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantitatively map which clinical diagnoses are associated with the terms “neurodivergence” and “neurodiversity” in empirical mental health literature via a scoping review.Scoping review (JBI methods; PRISMA-ScR)Expand

In plain English

Scoping review (JBI methods; PRISMA-ScR) that searched PubMed/Medline, Web of Science, Embase, and PsycINFO through 1 August 2025, identified 134 empirical studies (total N = 151,134 participants) that recruited people described as "neurodivergent" or "neurodiverse," and produced a descriptive quantitative mapping (counts/proportions) of the clinical diagnoses associated with those terms across included studies.

Key findings

  • Included 134 studies (N = 151,134) identified in systematic searches up to Aug 1, 2025.
  • Participant identification within included studies was primarily via self-reported diagnoses (56 studies; 41.8%) or self-identification as neurodivergent/neurodiverse (50 studies; 37.3%).
“Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research: A Scoping Review.”
What this piece can’t prove
  • Mapping is based on counts of diagnoses reported across included studies rather than pooled participant-level prevalence; heterogeneity in study design and reporting limits quantitative comparability.
  • Substantial reliance on self-reported diagnoses and self-identification across included studies introduces variability in diagnostic ascertainment.
  • Some included studies did not specify diagnoses, reducing the specificity of the mapping.
2secondary dataDescribe how participants labeled “neurodivergent/neurodiverse” are operationally identified/recruited in the included studies (eg, self-reported diagnosis, self-identification, unspecified).Scoping review; descriptive mapping of identification/recruitment modesExpand

In plain English

Scoping-review mapping of how studies that recruited participants described as “neurodivergent” or “neurodiverse” operationally identified/recruited those participants. Across 134 included studies (151,134 participants), study-level counts show participants were most often identified via self-reported diagnoses (56 studies; 41.8%) or via self-identification (50 studies; 37.3%); 29 studies (21.6%) did not report any clinical diagnoses.

Key findings

  • In the set of included studies, participants labeled as neurodivergent/neurodiverse were most commonly identified via self-reported diagnoses (56 studies; 41.8%) or self-identification (50 studies; 37.3%), while 29 studies (21.6%) did not specify any clinical diagnoses.
“Participants were primarily identified through self-reported diagnoses (n = 56 [41.8%]) or self-identification (n = 50 [37.3%]).”
What this piece can’t prove
  • Relies on reporting in included studies; 21.6% of studies did not specify clinical diagnoses, limiting completeness of the mapping.
  • Study-level counts do not convey the distribution of participants across identification modes (participant-level breakdown not provided in abstract).

1 further detail could not be confirmed from the summary.

3otherProvide interpretive implications for clinical/research terminology use (recommend prioritizing precise diagnostic descriptors; reserve neurodivergent for identity/self-identification contexts).Narrative interpretive recommendationExpand

In plain English

Based on the scoping review's mapping of diagnoses associated with the terms, the authors interpret that 'neurodivergence' and 'neurodiversity' lack clinical and diagnostic specificity (the review found a heterogeneous range of associated diagnoses—most commonly autism and ADHD—and 21.6% of studies did not specify any clinical diagnoses). They conclude this lack of specificity can introduce substantial heterogeneity in research focused on clinical categories and therefore recommend prioritizing precise diagnostic descriptors in clinical practice and research involving clinically defined conditions, while reserving 'neurodivergent' for studies and contexts centered on self-identification and identity.

Key findings

  • The terms 'neurodivergence' and 'neurodiversity' lack clinical/diagnostic specificity; the scoping review identified a heterogeneous range of associated diagnoses (most commonly autism and ADHD), and 21.6% of included studies did not specify any clinical diagnoses, which the authors state may introduce substantial heterogeneity in research focused on clinical categories.
  • Recommendation to prioritize precise diagnostic descriptors in clinical practice and in research that involves clinically defined conditions.
“While neurodivergence and neurodiversity are valuable for capturing lived experience, their lack of specificity may introduce substantial heterogeneity in research focused on clinical categories.”
What this piece can’t prove
  • This unit represents an interpretive/recommendatory component of the scoping review (Conclusions and Relevance) rather than new empirical research.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 33 candidate papers

And 27 more candidates considered.